• Overview
  • Eligibility
  • More info
  • Locations

(NCT02772016)

Seventy-two pregnant patients diagnosed of minor or intermediate beta thalassemia with mild anemia were randomly assigned to treatment group and control group. Patients in the treatment group were given 15 g of Colla corii asini in powder form daily for 4 weeks while the control group were observed and followed up in the same period without any treatments. Levels of hemoglobin(Hb), serum iron (SI), serum ferritin (SF) and three types of hemoglobin components [adult hemoglobin (HbA), fetal hemoglobin (HbF), minor adult hemoglobin (HbA2)] were measured before and after treatments.
  • Drug: Colla corii asini
    15 g of Colla corii asini in powder form daily for 4 weeks
    Ages eligible for Study
    20 Years to 35 Years
    Genders eligible for Study
    Female
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Inclusion Criteria:
    • pregnant women diagnosed as thalassemia carriers by genetic test with clinical presentation of minor or intermediate β- thalassemia;
    • patients with mild anemia (80 g/L≤ Hb<110 g/L) prior to study enrollment;
    • singleton pregnancy;
    • patients having not received blood transfusion or any forms of anti-anemia treatment in Western Medicine or Traditional Chinese Medicine in the last 12 weeks;
    • informed consent obtained.
    Exclusion Criteria:
    • patients with severe thalassemia;
    • patients with severe anemia (Hb<80 g/L) prior to study enrollment;
    • twin or multiple pregnancies;
    • patients with any of the following abnormalities: immunodeficiency, primary diseases involving cardiovascular system, liver, kidney, gastrointestinal tract, endocrine system and hematological system;
    • allergic to two or more drugs;
    • patients with mental illness or poor compliance to medical treatment;
    • patients having received blood transfusion or any forms of anti-anemia treatment in Western medicine or Traditional Chinese Medicine in the last 12 weeks;
    • no informed consent obtained.

    1 locations

    China (1)
    • the first affiliated hospital of Guangzhou University of Chinese Medicine
      recruiting
      Guangzhou, Guangdong, China, 510405
    Status:
    unknown
    Type:
    Interventional
    Phase:
    0
    Start:
    28 February, 2015
    Updated:
    10 May, 2016
    Participants:
    90
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!